Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients

British Journal of Haematology

Volumn 120, Issue 3, 2003, Pages 405-412

  Galimberti, Sara ^a   Morabito, Fortunato ^b   Guerrini, Francesca ^a   Palumbo, Giuseppe Alberto ^c   Azzará, Antonio ^a   Martino, Massimo ^b   Benedetti, Edoardo ^a   Di Raimondo, Francesco ^c   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Bone Marrow Transplant Unit   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Harvest; Minimal residual disease; Multiple myeloma

Indexed keywords

CD34 ANTIGEN;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CANCER STAGING; CONTAMINATION; FEMALE; GENE REARRANGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; BONE MARROW PURGING; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037323884     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04106.x     Document Type: Article

References (23)

1. Attal, M., Harrousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective, randomized trial of autologous blood stem cell transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 91-97.
2. Barbui, A.M., Galli, M., Dotti, G., Belli, N., Borleri, G., Gritti, G., Bellavita, P., Viero, P., Comotti, B., Barbui, T. & Rambaldi, A. (2002) Negative selection of peripheral blood stem cells to support a tandem autologous transplantation programme in multiple myeloma. British Journal of Haematology, 116, 202-210.
3. Cavo, M., Terragna, C., Martinelli, G., Ronconi, S., Zamagna, E., Tosi, P., Lemoli, R.M., Benni, M., Pagliani, G., Bandini, G. & Tura, S. (2000) Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma. Blood, 96, 355-357.
4. Corradini, P., Voena, C., Tarella, C., Astolfi, M., Ladetto, M., Palumbo, A., Van Lint, M.T., Bacigalupo, A., Santoro, A., Musso, M., Majolino, I., Boccadoro, M. & Pileri, A. (1999) Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. Journal of Clinical Oncology, 17, 208-215.
5. Cremer, F.W., Kiel, K., Wallmeier, M., Goldscmidt, H. & Moos, M. (1997) A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma. Annals Oncology, 8, 633-636.
6. Di Simone, D., Galimberti, S., Mattii, L. & Petrini, M. (1997) c-Jun and GST-μ expression in human plasma cells. Haematologica, 82, 69-70.
7. Durie, B.G. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854.
8. Galimberti, S., Brizzi, F., Mameli, M. & Petrini, M. (1999) An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detection. Leukemia Research, 23, 921-929.
9. Gore, M.E., Selby, P.J., Viner, C., Clark, P.I., Meldrum, M., Millar, B., Bell, J., Maitland, J.A., Milan, S. & Judson, I.R. (1989) Intensive treatment of multiple myeloma and criteria for complete remission. Lancet, 2, 879-882.
10. Harrousseau, J.L. & Attal, M. (1997) The role of autologous hematopoietic stem cell transplantation in multiple myeloma. Seminars in Haematology, 34, 61-66.
11. Lemoli, R.M., Fortuna, A., Raspadori, D., Ventura, M.A., Martinelli, G., Gozzetti, A., Leopardi, G., Ratta, M., Cavo, M. & Tura, S. (1997) Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma. Leukemia and Lymphoma, 26, 1-11.
12. Lopez-Perez, R., Garcia-Sanz, R., Gonzales, D., Balanzategui, A., Chillon, M.C., Alaejos, I., Mateos, M.V., Caballero, M.D., Corral, M., Orfao, A., Gonzales, M. & San Miguel, J.F. (2001) Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 28, 665-672.
13. Majolino, I., Vignetti, M., Meloni, G., Vegna, M.L., Scime', R., Tringali, S., Amaddii, G., Coser, P., Tribalto, M., Raimondi, R., Bergonzi, C., Sajeva, M.R., Sica, S., Ferrando, F., Messina, G. & Mandelli, F. on behalf of the GITMO (Gruppo Italiano Traplanti di Midollo Osseo) (1999) Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Haematologica, 84, 844-852.
14. Mehra, S., Messner, H., Minden, M. & Chaganti, R.S. (2002) Molecular cytogenetic characterization of non Hodgkin lymphoma cell lines. Genes, Chromosomes and Cancer, 33, 225-234.
15. Owen, R.G., Johnson, R.J., Rawstrom, A.C., Evans, P.A., Jack, A., Smith, G.M., Child, J.A. & Morgan, G.J. (1996) Assessment of IgH PCR strategies in multiple myeloma. Journal of Clinical Pathology, 49, 672-675.
16. Porrata, L.F., Gertz, M.A., Inwards, D.I., Litzow, M.R., Lacy, M.Q., Tefferi, A., Gastineau, D.A., Dispenzieri, A., Ansell, S.M., Micallef, I.N.M., Geyer, S.M. & Svetomir, N.M. (2001) Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or Non Hodgkin Lymphoma. Blood, 98, 579-585.
17. Reed, T.J., Reid, A., Wallberg, K., O'Leary, T.J. & Frizzera, G. (1993) Determination of B-cell clonality in paraffin-embedded lymph nodes using the polymerase chain reaction. Diagnostic in Molecular Pathology, 2, 42-49.
18. Ritter, J.H., Wick, M.R., Adesokan, P.N., Fitzgibbon, J.F., Zhu, X. & Humphrey, P.A. (1997) Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement. American Journal of Clinical Pathology, 108, 60-68.
19. Szczepek, A.J., Bergsagel, P.L., Axelsson, L., Brown, C.B., Belch, A.R. & Pilarski, L.M. (1997) CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements. Blood, 89, 1824-1833.
20. Tricot, G., Gazitt, Y., Leemhuis, T., Jagannath, S., Desikan, K.R., Siegel, D., Fassas, A., Tindle, S., Nelson, J., Juttner, C., Tsukamoto, A., Hallagan, J., Atkinson, K., Reading, C., Hoffman, R. & Barlogie, B. (1998) Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma. Blood, 91, 4489-4495.
21. Vescio, R., Schiller, G., Stewart, A.K., Ballester, O., Noga, S., Rugo, H., Freytes, C., Stadtmauer, E., Tarantolo, S., Sahebi, F., Stiff, P., Meharchard, J., Schlossman, R., Brown, R., Tully, H., Benyunes, M., Jacobs, C., Berenson, R., Di Persio, J., Anderson, K. & Berenson, J. (1999) Multicenter phase III trial to evaluate CD34+ selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood, 93, 1858-1868.
22. Voena, C., Ladetto, M., Astolfi, M., Provan, D., Gribben, J.G., Boccadoro, M., Pileri, A. & Corradini, P. (1997) A novel nested-PCR strategy for detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. Leukemia, 11, 1793-1798.
23. Willems, P., Verhagen, O., Segeren, C., Veenhuizen, P., Guikema, J., Wiemer, E., Groothuis, L., Jong, T.B., Kok, H., Bloem, A., Bos, N., Vellenga, E., Mensink, E., Sonneveld, P., Lokhorst, H., van Der Schoot, E. & Raymakers, R. (2000) Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Blood, 96, 63-70.